Durect Corporation Stock News

United Therapeutics (UTHR) delivered earnings and revenue surprises of -41.22% and 0.85%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

The Nasdaq Composite index tumbled by more than 550 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confide

CUPERTINO, Calif. , May 18, 2022 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Dr. James E.

Durect (DRRX) delivered earnings and revenue surprises of 0% and 21.03%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

DURECT Corp, Inc. (NASDAQ:DRRX ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Matthew Hogan - IR James Brown - Co-Founder, CEO, President & Director Norman Sussman - Ch

Alpine Immune Sciences, Inc. (ALPN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further

CUPERTINO, Calif., March 23, 2022 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Dr. James E.

DURECT Corporation's (DRRX) CEO Jim Brown on Q4 2021 Results - Earnings Call Transcript

Durect (DRRX) delivered earnings and revenue surprises of 40% and 204.04%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Durect (DRRX) delivered earnings and revenue surprises of 40% and 204.04%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zogenix (ZGNX) delivered earnings and revenue surprises of -8.89% and 1.46%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

In last trading session, DURECT Corporation (NASDAQ:DRRX) saw 0.32 million shares changing hands with its beta currently measuring 1.29. Company’s recent per share price level of $0.68 trading at $0.01 or 1.94% at ring of the bell on the day assigns it a market valuation of $158.60M. That closing price of DRRX’s stock is at … DURECT Corporation (NASDAQ:DRRX) Is Currently -252.94% Below Its 52-Week High, But Upside Potential Is Still There. Read More »

DURECT Corporation (NASDAQ:DRRX) with the stream of -6.64% also noticed, India Flotek Industries, Inc. (NYSE:FTK) encountered a rapid change of -10.83% in the last hour of Tuesdays trading session. DURECT The post Miraculous Stock: DURECT Corporation (NASDAQ:DRRX), Flotek Industries, Inc. (NYSE:FTK) appeared first on Stocks Equity .

Durect (DRRX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates co